Teva takes aim at Huntington's disease with 'Honestly HD' website
State sues Teva over Copaxone drug royalties - Israel News - The Jerusalem Post
Did Neurocrine Just Leave The Door Open For Teva In Tourette's? | Investor's Business Daily
Teva Tries to Put an End to the Opioid Wars - WSJ
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
New York Jury Holds Drugmaker Teva Liable in Opioid Crisis
Teva, amid massive restructuring, closes in on $3B cost-cutting goal | Fierce Pharma
Twenty More States Accuse Mylan, Teva and Others of Price Collusion - TheStreet
teva ceo News and latest stories | The Jerusalem Post
:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/tgam/IITRCH6KIBBTXLJ74B2DTSXL2M.jpg "U.S. to charge Teva with conspiring to raise prices of generic drugs, sources say - The Globe and Mail")
U.S. to charge Teva with conspiring to raise prices of generic drugs, sources say - The Globe and Mail
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Teva Launches DIY Events at Select Retailers Nationwide | Deckers Brands
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Attorney General Josh Stein Announces $4.5 Billion Settlement in Principle with Opioids Maker Teva - NCDOJ
ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units
Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel
Teva Pharmaceuticals May Have Lied in Opioid Case: NYAG
Teva Pharmaceuticals on Twitter: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Announces Collaboration with Publish Brand for Spring 2019 | Deckers Brands
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
New York Could Get $524M Under Opioid Settlements With Teva
Teva lied about opioid role, New York says
